Skip to main content
Communications Biology logoLink to Communications Biology
. 2024 Mar 29;7:380. doi: 10.1038/s42003-024-06078-9

Structure, function and substrate preferences of archaeal S-adenosyl-l-homocysteine hydrolases

Lars-Hendrik Koeppl 1,#, Désirée Popadić 1,#, Raspudin Saleem-Batcha 1,#, Philipp Germer 1, Jennifer N Andexer 1,
PMCID: PMC10978960  PMID: 38548921

Abstract

S-Adenosyl-l-homocysteine hydrolase (SAHH) reversibly cleaves S-adenosyl-l-homocysteine, the product of S-adenosyl-l-methionine-dependent methylation reactions. The conversion of S-adenosyl-l-homocysteine into adenosine and l-homocysteine plays an important role in the regulation of the methyl cycle. An alternative metabolic route for S-adenosyl-l-methionine regeneration in the extremophiles Methanocaldococcus jannaschii and Thermotoga maritima has been identified, featuring the deamination of S-adenosyl-l-homocysteine to S-inosyl-l-homocysteine. Herein, we report the structural characterisation of different archaeal SAHHs together with a biochemical analysis of various SAHHs from all three domains of life. Homologues deriving from the Euryarchaeota phylum show a higher conversion rate with S-inosyl-l-homocysteine compared to S-adenosyl-l-homocysteine. Crystal structures of SAHH originating from Pyrococcus furiosus in complex with SlH and inosine as ligands, show architectural flexibility in the active site and offer deeper insights into the binding mode of hypoxanthine-containing substrates. Altogether, the findings of our study support the understanding of an alternative metabolic route for S-adenosyl-l-methionine and offer insights into the evolutionary progression and diversification of SAHHs involved in methyl and purine salvage pathways.

Subject terms: Enzymes, X-ray crystallography


The biochemical characterisation of S-adenosyl-l-homocysteine hydrolases from all three domains of life supports the assumption that alternative routes for methyl metabolism coupled to purine salvage exist in some classes of Euryarchaeota.

Introduction

The methylation of small molecules as well as nucleic acids and proteins is an important modification in nature found in various biological processes such as drug metabolism, epigenetic regulation, and cancer development13. The methyl groups for such modifications are provided by a global metabolic pathway, the methyl cycle. The enzyme cofactor needed for this reaction is S-adenosyl-l-methionine (SAM), which is converted to S-adenosyl-l-homocysteine (SAH) by methyltransferases (MTs; EC 2.1.1.x) once the methyl group is transferred to a substrate, e.g. DNA, RNA, proteins, or small molecules4,5. MTs are a diverse group of enzymes installing the methyl group onto O, N, S, and C atoms, among others. In cells, the by-product SAH is salvaged as part of a complex regulation system, as SAH is known to act as a negative feedback inhibitor on most MTs, reducing the methylation rate in the cell6.

The SAM/SAH ratio is controlled by different enzymatic pathways (Fig. 1). 5´-Methylthioadenosine (MTA)/SAH nucleosidase (MTAN; EC 3.2.2.9) irreversibly cleaves the glycosidic bond of SAH to adenine and S-ribosyl-l-homocysteine, which is further transformed to l-homocysteine (Hcy) by the S-ribosyl-l-homocysteine lyase LuxS (EC 4.4.1.21)7. Alternatively, SAH hydrolase (SAHH; EC 3.3.1.1) reversibly converts SAH to adenosine and Hcy7,8. Hcy is re-methylated to l-methionine, a building block for SAM formation, by different enzymes911.

Fig. 1. SAH degradation pathways.

Fig. 1

SAH is either reversibly cleaved to adenosine and Hcy by SAHH (green) or degraded in two steps catalysed by MTAN and LuxS (orange). The pathway discovered in Methanocaldococcus jannaschii contains the deamination step of SAH to SIH, which is subsequently cleaved to inosine and Hcy by SIHH (blue).

Some organisms feature both routes (MTAN/LuxS and SAHH) for SAH degradation, while others only possess one, or in rare cases, e.g. in Mycoplasma genitalium, neither pathway12. A third pathway was identified in the archaeon Methanocaldococcus jannaschii. A 5´-deoxyadenosine deaminase (DadD; EC 3.5.4.41) catalyses the deamination of SAH to S-inosyl-l-homocysteine (SIH)13, which is subsequently cleaved to inosine (Ino) and Hcy by the SAHH homologue from M. jannaschii. For SAH, no activity was detected and therefore the enzyme was reclassified as an SIH hydrolase (SIHH; EC 3.13.1.9)14.

A homologue of DadD, an MTA/SAH deaminase (EC 3.5.4.31/28), was found in Thermotoga maritima in a structure-based activity prediction in 2007, indicating the same metabolic pathway as in the archaeon M. jannaschii. The SAHH from this thermophilic bacterium was shown to catalyse SIH cleavage in addition to SAH cleavage (with KM values in the same order of magnitude)15. In 1988, a putative homologue of the deaminase was identified in Streptomyces flocculus (Streptomyces albus ATCC 13257) and proposed to be part of a major route in SAH metabolism, as SIH was isolated from the organism16,17. In addition to the SAHH homologues from M. jannaschii14 and T. maritima15 that were tested for SIH cleavage or synthesis activity, one bacterial representative from Alcaligenes faecalis was tested with nucleoside analogues in the synthesis reaction in 1984. With inosine, the enzyme showed almost no activity (0.5%) compared to adenosine as substrate18.

SAHHs are highly conserved in all domains of life and have been extensively characterised biochemically, as well as structurally, over the last century19,20. As the products of the SAHH-catalysed cleavage are rapidly removed in vivo, this reaction is preferred in cells, while SAH synthesis is the main reaction taking place in vitro21,22. SAHH depends on the cofactor nicotinamide adenine dinucleotide in its oxidised form (NAD+), which is self-regenerated during the catalytic cycle2326. Briefly, the 3´-OH group of the adenosine ribose is oxidised to a ketone by reducing NAD+ to NADH. The now more acidic C4´ proton is abstracted to form a carbanion intermediate, followed by the release of Hcy. Water is added through a Michael-type addition to the C4´–C5´ double bond23. The last step is the reduction of the ketone to form adenosine under re-oxidation of NADH to NAD+; thus, the cofactor is ready for the next reaction cycle either in the cleavage or synthesis direction (Supplementary Fig. S25 online).

The protein structure of SAHHs features three domains in a monomer, the active form is usually a homotetramer19 (Fig. 2a, b). The substrate-binding domain is located next to the cofactor-binding domain, each showing a Rossmann fold19. The C-terminus is a smaller dimerisation domain. The substrate-binding and the cofactor-binding domains are connected by a two-part hinge element. SAHHs have been shown to alternate between two conformations differing in the relative positions of the substrate- and cofactor-binding domains (Fig. 2c). In the “open” conformation, with no substrate bound, the domains are away from each other providing access to the active site (PDB IDs: 3X2F and 4LVC)27,28. In the “closed” conformation, the substrate-binding domain reorients by about 18° relative to the cofactor-binding domain and both domains form the active site interacting with a substrate or inhibitor29,30. In addition to the overall conformational state, a critical loop region comprises a pair of histidine (His) and phenylalanine (Phe) acting as gate residues that provide a channel for the substrate to access the active site; it is highly conserved over SAHH sequences of all domains of life31. This so called “molecular gate” loop displays a plasticity that opens (His-OUT) and shuts (His-IN) upon different ligation states via a 180° flip of the peptide plane between Cα atoms of His and Phe (Fig. 2c)31.

Fig. 2. Structural features of SAHHs.

Fig. 2

a An enzyme monomer consists of the C-terminal dimerisation domain (orange), the substrate-binding domain (blue) and the cofactor-binding domain (red) connected by a two-part hinge element (grey) (PDB ID: 7R38). b The monomers oligomerise to form a dimer of a dimer (PDB ID: 7R38). c The monomers alter their conformation between the open and closed state (PDB ID: 4LVC). Within the closed conformation, a pair of His and Phe can act as gate residues (PDB IDs: 7R37 and 7R38).

Multiple protein structures from bacterial and eukaryotic SAHH enzymes have been determined26,28,31,32 (Supplementary Table S4 online); however, no protein structure originating from the domain of Archaea has been published. The archaeal enzymes are predicted to show similar architecture as their eukaryotic and bacterial relatives but display remote differences such as a shortened C-terminus and a missing 40 amino acid segment in the catalytic domain among other smaller deletions12,33. Further, an HxTxQ(E) sequence signature (with x corresponding to any amino acid) is found in the substrate-binding domain of eukaryotic and bacterial enzymes, while extremophile SAHHs have been suggested to feature a different motif, HxT(E)xK19. The His residue is important for catalysis (Supplementary Fig. S25 online), while Thr(Glu) and Gln(Glu) have been suggested to stabilise the nucleobase in the active site via hydrogen bonds19,25. The residue Gln(Glu) was also found to play a role in the conformational changes of the enzyme, regulating its activity34.

The discovery of SIHHs14 prompted us to study the tertiary structures and biochemical properties of SAHH enzymes from archaea and to identify their differences from bacterial and eukaryotic homologues characterised biochemically. To the best of our knowledge, we show here the first archaeal SAHH/SIHH crystal structures within the Euryarchaeota and Crenarchaeota phyla in the presence of hypoxanthine derivatives (inosine and SIH) of the recently proposed alternate SAM salvage pathway13. In addition, our investigation of the substrate ranges of different SAHHs led to the identification of more organisms potentially featuring alternative SAM regeneration pathways. Altogether these findings result in a substantial support of the alternate SAM salvage pathway and the importance of methyl metabolism in archaea.

Results and discussion

Overview of investigated SAHHs/SIHHs

In this work, SAHHs/SIHHs from archaea, bacteria, and eukaryotes were characterised biochemically (Supplementary Table S2 online). The homologues from M. jannaschii (MjSIHH) and T. maritima (TmSAHH) were previously reported to have SIH cleavage activity14,15,27,35. Structures of archaeal SAHHs were determined from three organisms: Methanococcus maripaludis (MmaSAHH), Pyrococcus furiosus (PfuSAHH)36, and Sulfolobus acidocaldarius (SacSAHH). In addition, the structure of SAHH from Mus musculus (MmSAHH) was determined in complex with inosine.

The substrate range differs depending on the origin of the enzyme

All enzymes were tested in both reaction directions with the hypoxanthine- and adenine-containing substrates. As SAH/SIH cleavage is not preferred in vitro and consequently hard to follow, the reaction was coupled to Hcy S-methylation catalysed by Hcy S-MT (HSMT; EC 2.1.1.10)9 to drive the reaction forward by removing one of the products (Fig. 3b–d). The following analysis with HPLC-DAD allows the direct identification of hypoxanthine- vs. adenine-containing substrate, which is not possible in previously described coupled colorimetric and photometric assays for SAHHs37,38. As a side-product, the corresponding nucleobase (adenine or hypoxanthine) was detected in all set-ups, as previously described39 (Fig. 3b, c). In some reports, SAHH activity was only observed with externally added NAD+4042, while there are also examples showing SAH cleavage and synthesis activity without the addition of extra NAD+32,36,43. All enzymes tested in this work were active without the addition of NAD+.

Fig. 3. Phylogenetic tree of investigated SAHHs/SIHHs with substrate range and used enzyme assays.

Fig. 3

a The sequence-based phylogenetic tree groups the tested SAHHs/SIHHs according to their substrate preference. Nevertheless, this does not fully correspond to the phylogenetic relatedness of the respective organisms: Representatives from Crenarchaeota exclusively accept SAH as substrate; in contrast, most family members tested from Euryarchaeota and a closely related thermophilic bacterium accept both SAH and SIH, including some homologues that clearly prefer SIH. Except for CgSAHH and LlSAHH, bacterial and eukaryotic SAHHs accept both substrates with a substantial preference for SAH. b PfuSAHH-catalysed cleavage of SIH, and (c) SacSAHH-catalysed cleavage of SAH, both with and without addition of ScHSMT (and negative control without enzymes). d The addition of the second enzyme ScHSMT increases the conversion of the cleavage reaction. e The thiol scavenger 5,5’-dithiobis-2-nitrobenzoic acid (DTNB) reacts with Hcy to form a mixed disulphide and  2-nitro-thiobenzoic acid (TNB). For reactions performed at 70 °C it was used instead of ScHSMT to increase the conversion of SAH/SIH cleavage.

Under the chosen conditions, all SAHHs/SIHHs were active for SAH cleavage and synthesis (Table 1), including the homologue from M. jannaschii (MjSIHH) previously described to be specific for SIH as substrate14 (Supplementary Fig. S10; all chromatograms in Figs. S4S21 online). Nevertheless, this enzyme clearly prefers the hypoxanthine-containing compounds over the adenine-containing ones. The same results were observed for other representatives from Euryarchaeota (MiSAHH, MmaSAHH, PfuSAHH, and TkSAHH). As described before, the bacterial TmSAHH, which is closely related to these euryarchaeal enzymes (Fig. 3a), catalysed SAH and SIH cleavage and synthesis15, in our hands also with a strong preference for the hypoxanthine derivatives. In contrast, another subgroup of SAHHs from euryarchaeal origin (McSAHH, MeSAHH, MhSAHH, and MtSAHH) showed a substantial preference for the synthesis and cleavage of SAH over SIH. In the case of MeSAHH, neither synthesis nor cleavage of SIH was catalysed while the other enzymes of this subset showed slight catalytic activity for SIH synthesis. Comparable results were obtained for the SAHHs from Crenarchaeota (SacSAHH and SsoSAHH), which were only active with SAH or adenosine as substrates. These findings strongly support the assumption that alternative routes for methyl metabolism coupled to purine salvage exist within some classes of Euryarchaeota and closely related bacteria.

Table 1.

Overview of SAHHs biochemically tested in this work

Enzyme Organism Phylum/Kingdom SAH Cleavage/Synthesis SIH Cleavage/Synthesis Figure SI online
SacSAHH Sulfolobus acidocaldarius Crenarchaeota +++/+++ −/− S4
SsoSAHH Saccharolobus solfataricus Crenarchaeota +++/+++ −/− S5
McSAHH Methanocella conradii Euryarchaeota +++/++ −/+ S6
MeSAHH Methanohalobium evestigatum Euryarchaeota +/++ −/− S7
MhSAHH Methanohalophilus halophilus Euryarchaeota ++/++ −/+ S8
MiSAHH Methanocaldococcus infernus Euryarchaeota +/+ ++/++ S9
MjSIHH Methanocaldococcus jannaschii Euryarchaeota +/+ +++/+++ S10
MmaSAHH Methanococcus maripaludis Euryarchaeota +/+ +++/+++ S11
MtSAHH Methanothrix thermoacetophila Euryarchaeota +++/++ −/+ S12
PfuSAHH Pyrococcus furiosus Euryarchaeota +/++ +++/+++ S13
TkSAHH Thermococcus kodakarensis Euryarchaeota +/+ +++/+++ S14
CgSAHH Corynebacterium glutamicum Actinomycetota +++/+++ −/− S15
PaSAHH Pseudomonas aeruginosa Pseudomonadota +++/+++ +/++ S16
SaSAHH Streptomyces albus Actinomycetota +++/+++ −/+ S17
SfSAHH Streptomyces flocculus Actinomycetota +++/+++ −/+ S18
TmSAHH Thermotoga maritima Thermotogota +/+ +++/+++ S19
LlSAHH Lupinus luteus Plantae +/+++ −/− S20
MmSAHH Mus musculus Animalia +++/+++ +/+++ S21

Conversions indicated for the cleavage are based on reactions coupled to ScHSMT.

+++High conversion ( >70%), ++Medium conversion (30–70%), +Low conversion ( < 30%), - no conversion.

In previous work, we successfully used MmSAHH for an in vitro SAM regeneration cycle with alternative nucleobases including hypoxanthine44. This activity was now confirmed in the individual cleavage and synthesis reactions; however, reactions with SAH were in this case preferred. A similar pattern was observed for the SAHH from the bacterium Pseudomonas aeruginosa, while neither the representative from Corynebacterium glutamicum nor from the plant Lupinus luteus accepted inosine or SIH as substrates. As SIH had been described as a metabolite in S. flocculus, along with the presence of an SAH deaminase16,17, we tested SAHHs from two Streptomyces species (SaSAHH and SfSAHH). In both cases a low activity for SIH synthesis was detected; however, no activity for SIH cleavage (Supplementary Figs. S17 and S18 online). It might be that SIH is metabolised by other enzymes in these bacteria, suggesting an alternative SAH metabolism pathway than the one described for Euryarchaeota and archaeal-type bacteria.

Increased temperatures do not influence the substrate preferences

So far, the substrate preferences of archaeal, bacterial, and eukaryotic SAHH/SIHH representatives were tested at 37 °C to investigate their applicability in a multi-enzyme SAM regeneration cycle44. Some of the archaeal (PfuSAHH, TkSAHH, McSAHH, MiSAHH, MtSAHH, MjSIHH, SacSAHH, and SsoSAHH) as well as archaeal-type (TmSAHH) enzymes are derived from (hyper-)thermophilic organisms. TmSAHH produced and purified at room temperature was previously described to require thermal activation to attain enzymatic activity27,42. However, in our hands TmSAHH, as well as the other thermophilic enzymes, was enzymatically active without previous thermal activation. Assays to test the influence of higher temperatures on the substrate preferences were performed at 70 °C in SAH/SIH synthesis and cleavage directions with two selected model enzymes, PfuSAHH (Euryarcheota) and SacSAHH (Crenarchaeota). For reactions performed at 70 °C, HSMT from Saccharomyces cerevisiae (ScHSMT) was replaced by 5,5’-dithiobis-2-nitrobenzoic acid (DTNB). It acts as thiol scavenger reacting with Hcy in stoichiometric amounts to form a mixed disulphide and 2-nitro-thiobenzoic acid (TNB), and therefore shifts the reaction equilibrium to the product side37,45 (Fig. 3e). The suitability of DTNB as substitute for ScHSMT was tested beforehand at 37 °C (Supplementary Fig. S22 online). At 70 °C, PfuSAHH still showed a clear preference for SIH synthesis and cleavage compared to SAH (Supplementary Fig. S23 online). For SacSAHH, the conversion with the unfavoured substrates was slightly higher compared to the reactions performed at 37 °C; nevertheless, the enzyme still showed a substantial preference for SAH synthesis and cleavage (Supplementary Fig. S24 online). This strongly indicates that the tested SAHHs/SIHHs show the same substrate preferences at both temperatures. Increased conversion of SacSAHH-catalysed SIH cleavage suggests that they could degrade small amounts of SIH under higher living temperatures.

Different motifs for binding the nucleobase of the substrate/product in the subgroups of archaea

The differences in substrate range among the investigated SAHHs/SIHHs prompted us to conduct a detailed sequential and structural comparison to identify the underlying molecular basis. A sequence alignment of the enzymes tested in this work (Supplementary Fig. S26 online), showed that MmSAHH as well as PaSAHH are missing a 40 amino acid segment in the catalytic domain as opposed to the other eukaryotic and bacterial representatives. All investigated archaeal SAHHs/SIHHs, except for MeSAHH and MhSAHH, also lack this structure segment as described before12,33. Another sequence feature discriminating MeSAHH and MhSAHH from the other archaeal and archaeal-type homologues is the length of their C-terminus. The majority of SAHHs/SIHHs analysed in this work containing a shortened C-terminus are (hyper-)thermophilic, confirming the assumption36 that the length of the C-terminus correlates with the thermophilicity of the enzymes46. Based on our sequence analyses, the fingerprint motif suggested to distinguish extremophile SAHHs from mesophilic enzymes19 can be further specified: Crenarchaeota and a large part of Euryarchaeota feature HxTxE as a signature, this matches the sequence signature of bacterial and eukaryotic representatives [HxTxE(Q)]. A subgroup of the euryarchaeal and archaeal-type bacterial SAHHs, including six homologues analysed in this study have an HxExK motif (Fig. 4). Based on the data on euryarchaeal sequences available in the UniProt database, this subgroup encompasses mainly the Methanococci, Thermococci, Methanobacteria, Hadesarchaea, Archaeoglobi and Methanosarcina; while euryarchaeal enzymes from various other classes (e.g. Methanocella and Methanophagales) feature the HxTxE motif as found in Crenarchaeota; in further classes (e.g. Methanomicrobia and Theionarchaea), there is no clear trend visible. Our experiments show that the homologues with a HxExK motif prefer SIH as substrate while enzymes with a HxTxE(Q) motif prefer SAH. These results infer that the fingerprint motif distinguishes SAH-preferring SAHHs from SIH-preferring SIHHs.

Fig. 4. Sequence analysis of nucleobase-binding motifs of SAHHs/SIHHs.

Fig. 4

Partial alignment of the amino acid sequences of SAHHs/SIHHs tested in this study. The fingerprint motifs are highlighted in grey while the other residues are coloured by conservation according to the BLOSUM62 algorithm.

Genomes from Euryarchaeota and archaeal-type bacteria encode a deaminase

In order to get more insight in the potential alternative SAH salvage pathway, a BLASTP47 search for a protein homologue of DadD from M. jannaschii (MjDadD, Fig. 1) in the organisms producing the SAHHs/SIHHs analysed in this work was performed. The genomes from all analysed Euryarchaeota, as well as from the archaeal-type bacterium T. maritima, were found to have a homologue encoded (Supplementary Table S6 online). This is inconsistent with the substrate scope of characterised archaeal SAHHs/SIHHs as the subgroup of the tested euryarchaeal McSAHH, MeSAHH, MhSAHH and MtSAHH showed no activity for SIH cleavage. Notably, the BLASTP search revealed multiple isoforms of MeSAHH (UniProt accessions: D7E8L4 and D7E8N1) and MhSAHH (A0A1L3PZV2) suggesting that those organisms contain more than one SAHH, with putatively different substrate preferences, as inferred from their fingerprint motif. For McSAHH and MtSAHH, no isoforms were found. In these organisms, SIH resulting from DadD catalysed SAH deamination needs to be degraded via a pathway without SAHHs/SIHHs. Hence, a BLASTP search for homologues of Escherichia coli MTAN (EcMTAN), cleaving SAH into adenine and S-ribosyl-l-homocysteine, was performed. Only C. glutamicum, T. maritima and L. luteus were found to encode an MTAN homologue (Supplementary Table S7 online). This suggests that in the organisms encoding a DadD and an SAHH only cleaving SAH, SIH is metabolised by another pathway. Moreover, the lack of MTAN homologues in Euryarchaeota encoding an SAHH preferring SIH but also accepting SAH as substrate, strongly indicates that those enzymes have a dual function for SIH and SAH metabolism. The organisms without an encoded SAH deaminase do not need their SAHH to degrade SIH in addition to SAH. A more detailed BLASTP search including all available entries in the UniProt database48 resulted in the identification of further homologues of MjDadD, exclusively within the domain of bacteria and the phylum of Euryarchaeota. This suggests that the alternative SAM regeneration pathway via SIH is indeed not present in all archaea, but only in a subgroup from the phylum of Euryarchaeota and closely related thermophilic bacteria. Due to their shared living environment, thermophilic bacteria were shown to have obtained genes via horizontal transfer from archaea49. The reason for substantial SIH degradation and synthesis by MmSAHH and PaSAHH remains yet unclear. Likely, there will be other amino acid residues involved in substrate recognition which are not obvious from the sequence alignments.

Architecture and domains of archaeal SAHHs

Thus far, the sequence comparison revealed differences concerning the constitution of the catalytic domain, the length of the C-terminus, and the composition of the signature motif binding the nucleobase moiety of substrates and products. A detailed structural analysis was performed to determine how those differences influence the three-dimensional structure of SAHHs/ SIHHs and effect the substrate preferences. The archaeal enzymes were an ideal model system as they show different substrate preferences; however, no structures of archaeal SAHHs have been published to date. Here, we present the structures of three archaeal SAHHs (PfuSAHH, MmaSAHH, SacSAHH); in addition, the structure of the eukaryotic MmSAHH was determined in complex with its unusual substrate inosine (Table 2). In all SAHH structures obtained, the NAD+ cofactor was present indicating that it was co-purified with the enzyme.

Table 2.

Summary of crystal structures solved in this study

Enzyme Substrate Cofactor Resolution Treatment PDB ID
PfuSAHH SIH NAD+ 2.0 Å 22–25 °C 7R38
PfuSAHH Inosine NAD+ 2.3 Å 22–25 °C 7R37
PfuSAHH Inosine NAD+ 2.0 Å 95 °C, 15 min 8QNO
MmaSAHH Inosine NAD+ 2.5 Å 22–25 °C 7R3A
SacSAHH Adenosine NAD+ 2.6 Å 22–25 °C 7R39
MmSAHH Inosine NAD+ 2.5 Å 22–25 °C 8COD

The molecules in the asymmetric unit in all the cases were almost identical, being superimposable with a root-mean-square deviation (r.m.s.d.) of 0.17–0.63 Å over 356–393 Cα atoms. Data collection and refinement statistics are summarised in Table 3.

The archaeal SAHH monomer contains the same three domains as previously studied SAHHs across other domains of life: substrate-binding domain, cofactor-binding domain, and C-terminal domain27,32,34,42,50. The binding modes of NAD+ at the cofactor-binding domain and inosine or adenosine in the substrate-binding domain of archaeal SAHHs are similar to those observed in other SAHHs of distinct origin (Fig. 5a–d)26,28,31,32,34,51,52. In this study, the nucleoside moieties of the three ligands, adenosine, inosine, and SIH, participate in a similar pattern of hydrogen-bonding and non-bonding interactions (Supplementary Table S5 online). Evaluating the euryarchaeal structures elucidated in this study, it supports the assumption that the Glu57 residue (in the HxExK motif, numbering according to PfuSAHH, Fig. 5c/d and S27A/B online) forms a hydrogen bond with the heterocyclic nitrogen atom N1 of the nucleoside, analogous to the Thr residue in crenarchaeal, bacterial and eukaryotic homologues (in the HxTxE motif, e.g. Thr53 in SacSAHH, Fig. 5a and S27D online). The Lys residue at the end of the motif is found in enzymes that prefer hypoxanthine-containing substrates; here, the positively charged side chain can form a hydrogen bond with the oxygen at C6 in inosine, as seen in the structures of PfuSAHH (Lys59 in Fig. 5e and S27A/B online) and MmaSAHH (Lys74 in Supplementary Fig. S27C online), contributing to the stabilisation of the substrate in the active site. The motif HxTxE found in SacSAHH (Crenarchaeota) shows the same interactions with the substrate adenosine as in bacterial and eukaryotic enzymes19. As described before19, we observed that the exo-amino group of adenosine bound in SacSAHH forms additional hydrogen bonds with the carbonyl oxygen atoms in the main chains of Glu342 and His344 indicating that the adenine ring is in its preferred tautomeric amino form. Regarding the structures of PfuSAHH and MmaSAHH with their preferred substrates inosine or SIH, the oxygen attached to C6 seems to form additional hydrogen bonds with the carbonyl oxygen atoms of Asp348 (PfuSAHH) or Asp362 (MmaSAHH) in the main chains. This suggests that the hypoxanthine ring is in the imino-hydroxy form (Fig. 5f), although inosine has been shown to be most stable in the amino-oxo form in water53. Analysis of superposed structures of MmSAHH with bound adenosine54 and bound inosine showed no substantial differences in the architecture of the substrate binding pocket depending on the bound substrate (Supplementary Fig. S28 online).

Fig. 5. Binding modes of substrates/products and the cofactor in archaeal SAHHs.

Fig. 5

a Mode of adenosine and NAD+ cofactor binding in the active site of SacSAHH (PDB ID: 7R39). b Mode of inosine and NAD+ cofactor binding in the active site of MmaSAHH (PDB ID: 7R3A). c Mode of SIH and NAD+ cofactor binding in the active site of PfuSAHH (PDB ID: 7R38). d Mode of inosine and NAD+ cofactor binding in the active site of PfuSAHH (PDB ID: 7R37). e Inosine is bound by the motif HxExK in the substrate-binding domain (cartoon representation; PDB ID: 7R37). f Tautomers of inosine. Ligands are represented as sticks.

Overall conformational states and the molecular gate of archaeal SAHHs

Different conformational states of SAHHs have been described, where the open conformation was observed with no bound substrate/product in the substrate-binding domain, while the protein with a bound substrate or analogue shows the overall closed conformation. An example is a structure (PDB ID: 4LVC) of a bacterial SAHH showing adenosine bound in three subunits displaying a closed conformation while the fourth, ligand-free, subunit is in an open conformation28. All archaeal SAHH complexes in this study also display a closed conformational state including the PfuSAHH complex with SIH bound as substrate.

In addition to the closed overall conformation of the PfuSAHH•NAD•SIH complex, the molecular gate loop displays a flexibility. The transitions between the overall conformation and the conformation of the gatekeeper residues are independent from each other. Yet, His298 and Phe299 forming the molecular gate in PfuSAHH can only act as gatekeepers in the closed conformation when substrate-binding domain and cofactor-binding domain form the channel, as described before28,31. Interestingly, the His298 residue alone displays a noticeable conformational difference in this study. In the inosine bound complex, His298 is situated within the active site staging a His-IN conformation (gate shut) where its imidazole ring is oriented towards the γ-carboxylate group of Asp128 with a distance of 4.2 Å. The Nδ1 group of His298 is oriented to the O5´ group of inosine with a distance of 2.7 Å. A similar pattern is observed for MmaSAHH and SacSAHH complexes. However, the rotamer conformation of His in the His-IN state of SacSAHH deviates from the rest of the His-IN conformations among the archaeal SAHHs (Fig. 6) in this study. This indicates that there are not only different His orientations possible in the His-OUT state55, but also in the His-IN state. Comparison of the MmSAHH structures with bound adenosine and inosine (Supplementary Fig. S29 online) and the structure of SacSAHH suggests that the rotamer conformation is not dependent on the bound nucleoside substrate. The His298 residue of PfuSAHH•NAD•SIH complex swings away from Asp128 by 10.4 Å and forms a hydrogen bond with the carboxylate group of Glu302 with a distance of 2.7 Å signifying a His-OUT conformation leaving an open molecular gate. In a previously described structure of the Lupinus luteus SAHH32, the channel is open (His-OUT) even though adenosine is bound, while in the SAHH structure from Mycobacterium tuberculosis the same trend is seen as for PfuSAHH with the channel closed (His-IN) with adenosine bound and channel opened with SAH bound31. Similarly, our complexes of PfuSAHH and MmaSAHH with inosine and the complex of SacSAHH with adenosine show a closed conformation state of the molecular gate in their active site (Fig. 6). In accordance with Manszewski et al., comparison of our structures with already published SAHH structures did not lead to an apparent correlation between the conformation of the gate residues and the bound substrates56. Instead, the state of the reaction catalysed by SAHHs may determine the conformation of the gatekeeper residues to protect the unstable 3´-keto intermediates from exposure to the aqueous environment, as proposed by Yang et al57.

Fig. 6. The molecular gate residues in the crystal structures of archaeal SAHHs from this study.

Fig. 6

The His residue states are represented as His-IN (IN) and His-OUT (OUT). a In the PfuSAHH•NAD•inosine complex (PDB ID: 7R37), the His gatekeeper residue is in the IN orientation thereby closing the channel entrance. b In the PfuSAHH•NAD•SIH complex (PDB ID: 7R38), the gatekeeper residue forms an OUT orientation leaving the channel entrance open. c For the MmaSAHH•NAD•inosine complex (PDB ID: 7R3A) the gatekeeper residue is in the IN orientation. d In the SacSAHH•NAD•adenosine complex (PDB ID: 7R39), the gatekeeper residue is in the IN orientation that makes the channel entrance shut and inaccessible. The side chain of the gatekeeper residue of SacSAHH (circled red) shows another rotamer conformation than in PfuSAHH and MmaSAHH.

Differences in archaeal compared to bacterial and eukaryotic SAHHs

While the protein sequences of archaeal SAHHs/SIHHs are highly conserved (Supplementary Fig. S32 online), the substrate range differs within the distinct phyla of archaea. The PfuSAHH•NAD•inosine and MmSAHH•NAD•inosine complexes determined in this work were used for structural comparison with the bacterial PaSAHH (PDB ID: 6F3N). Besides the different signature motifs binding the nucleobase moiety, the overall architecture of the macromolecular environment of active sites is comparable between those three enzymes (Fig. 7a). The PfuSAHH•NAD•inosine complex lacks a monovalent cation (Na+ for MmSAHH and K+ for PaSAHH) coordinated by the hinge element in proximity to the nucleobase binding pocket34,52 (Fig. 7b–d). The absence of a comparable monovalent cation was observed in all structures of archaeal enzymes. Therefore, the catalytic activity of archaeal enzymes might be independent from the presence of monovalent cations as previously seen for a cyanobacterial homologue from Synechocystis sp. PCC 680352.

Fig. 7. Overall structural comparison of euryarchaeal PfuSAHH with SAHHs from other domains.

Fig. 7

a Superposition of the active sites of SAHHs from bacterial (yellow), eukaryotic (blue), and archaeal (white) organisms with bound substrates and NAD+ cofactors (SBP: substrate-binding pocket; CBP: cofactor-binding pocket). b SBP of bacterial PaSAHH in complex with adenosine (ADN). Zn2+ and K+ are shown as yellow spheres (PDB ID: 6F3N34). c SBP of archaeal PfuSAHH in complex with SIH (PDB ID: 7R38). d SBP of eukaryotic MmSAHH in complex with inosine (INO). Na+ is shown as blue sphere (PDB ID: 8COD). e In PfuSAHH, the cofactors are loosely covered by the adjacent monomer while some room is visible between the monomers, indicating a less stable enzyme (PDB ID: 7R38). f In MmSAHH, the cofactors are tightly covered by the C-terminus of the adjacent monomer (PDB ID: 5AXA53).

Looking at the overall structure of archaeal SAHHs compared to their eukaryotic and bacterial counterparts, the major difference is the shortened C-terminus, which interacts with the cofactor bound to the neighbouring subunit. Due to the shortened C-terminus, the archaeal enzyme structures lack hydrogen bonds, which are formed between amino acids (Lys426 and Tyr430) of one subunit with the 2´- and 3´-hydroxy groups of the adenosine moiety and the pyrophosphate of NAD+ bound in the adjacent subunit, present in MmSAHH and other mesophilic homologues. Instead of interactions between C-terminal domains of neighbouring monomers, the major forces for stabilisation are provided by aromatic and hydrophobic amino acid residues at the interfaces of the tetramers36. In addition, the interfaces between the monomers of the archaeal SAHHs show a cleft, when looking at the surface representation (Fig. 7e). This is not visible in eukaryotic SAHHs, such as the one from mouse (Fig. 7f); also because of the longer C-terminus that covers the cofactor. This means the cofactor is more exposed to the environment in archaea, and indicates a less stable tetrameric form for archaeal SAHHs/SIHHs, as fewer interactions are found between the monomers. TmSAHH was found to require a much higher concentration of NAD+, which was linked back to the shortened C-terminus, impacting the binding affinity27. TmSAHH has the shortest C-terminus, which is three amino acids shorter than the archaeal ones. All SAHHs/SIHHs in this work (including TmSAHH) were active without the addition of NAD+ at 37 °C and thus no dependency between concentration of NAD+ and length of C-terminus was observed in our hands. Moreover, recombinant TmSAHH was described to only be enzymatically active after a heat-induced conformational change27,42. To further investigate this observation, we used recombinant enzymes either previously preincubated at 95 °C or permanently handled at room temperature for crystallisation of the hyperthermophilic PfuSAHH in complex with inosine. Comparison of both structures showed no substantial differences in the conformation of the differently treated enzymes (Supplementary Fig. S30 online). Independent of the previous thermal treatment, PfuSAHH, as the other archaeal homologues, formed stable homotetramers in the crystal. To verify the arrangement of individual units in the multimeric assembly of the archaeal SAHH crystal structures, tetramers were constructed and analysed for each SAHH individually in their respective space groups using PDBePISA58. The prediction analysis of PfuSAHH tetramers (both inosine and SIH complexes) showed an average value for the solvation free energy on formation of the assembly (ΔGint) of −129.0 kcal mol−1. Similarly, MmaSAHH tetramers and SacSAHH tetramers exhibited an average ΔGint value of −133.5 kcal mol−1 and −127.5 kcal mol−1, respectively. In comparison, selected eukaryotic SAHHs with a long C-terminus, such as MmSAHH tetramers (both inosine and adenosine complexes), showed an average ΔGint of −186.7 kcal mol−1. These predictions suggest that the eukaryotic SAHH tetramers display more favourable solvation free energy than the archaeal SAHH tetramers. Regarding the stability of archaeal SAHH tetramers, the shortened C-terminal domain was speculated to either be useful for intramolecular motion at high temperature and prevent denaturation based on a protein model for PfuSAHH36, or to positively affect the thermostability of the enzyme27. This is in accordance with the analyses provided in this study.

Conclusion

In this work, we present the biochemical characterisation of various archaeal, bacterial, and eukaryotic SAHH/SIHH homologues revealing different substrate preferences. While archaeal enzymes deriving from the Crenarchaeota phylum (SacSAHH and SsoSAHH) show catalytic activity only with SAH, homologues from T. maritima and the euryarchaeal classes of Methanococci and Thermococci (MiSAHH, MjSIHH, PfuSAHH, TkSAHH, and MmaSAHH) show higher catalytic activity with SIH. Our biochemical characterisation together with the bioinformatical analyses indicate that multiple more euryarchaeal organisms employ a pathway for methyl metabolism and purine salvage using a deamination step. As some archaea evolutionary prefer purine salvage pathways with inosine and hypoxanthine as intermediates, this might not only apply for the metabolism of SAM but various other cofactors. Moreover, it is reasonable to investigate the incorporation of hypoxanthine-derivatives into other enzyme cofactors in these organisms. Similar pathways have been actually observed in the archaeon Thermococcus kodakarensis, in which a deamination of NAD+ has been reported59. In addition to the biochemical investigations, we provide structural insights into SAHHs/SIHHs originating from archaeal organisms. The archaeal enzymes show the same binding modes for the cofactor NAD+ as well as for the substrates inosine/adenosine and SIH/SAH as homologues from other domains of life. The absence of a monovalent cation in proximity to the active site suggests that the catalytic activity of archaeal SAHHs/SIHHs is independent of monovalent cations. The shortened C-terminal domain of archaeal SAHHs/SIHHs has an influence on their tertiary and quaternary arrangement showing differences compared to bacterial and eukaryotic homologues. In summary, our functional and structural knowledge of SAHHs/SIHHs strongly promotes the existence of an alternate route for methyl metabolism and purine salvage, which might run in parallel with the canonical pathway, as SAH is also accepted as a substrate.

Methods

Materials

Substrates and reference standards were purchased in the highest purity available from Sigma-Aldrich (adenosine, Hcy, hypoxanthine, inosine, SAH, S-methyl-l-methionine), and AppliChem (adenine). Ingredients for buffers and cultivation media were purchased from Carl Roth.

Cloning, expression, and protein purification

Genes of CgSAHH, LlSAHH, MjSIHH, MmaSAHH, MmSAHH, PaSAHH, PfuSAHH, SacSAHH, SsoSAHH, TmSAHH, and MjDadD were purchased as synthetic DNA strings from Invitrogen (Thermo Fisher Scientific, Waltham, MA, USA). SaSAHH, SfSAHH and TkSAHH were cloned directly from genomic DNA. The genes were amplified by PCR and cloned into pET28a(+) using T4 DNA ligase (New England Biolabs GmbH, Frankfurt am Main, Germany) or In-Fusion Cloning (Takara Bio Europe, Saint-Germain-en-Laye, France). All primers are listed in Supplementary Table S1 online. For McSAHH, MeSAHH, MhSAHH, MiSAHH, and MtSAHH, pET28a(+) based plasmids encoding the enzymes were ordered from BioCat GmbH (Heidelberg, Germany). The l-homocysteine S-methyltransferase from Saccharomyces cerevisiae (ScHSMT) was cloned from genomic DNA of baker’s yeast (primers used: ScHSMT-NdeI-fwd 5’-TATATACATATGAAGCGCATTCCAATCAAAG-3’ and ScHSMT-HindIII-rev 5’-TATATAAGCTTAGGAGTATTTATCTACAGCTGATGC-3’) into pET28a(+) using T4 DNA ligase (New England Biolabs GmbH, Frankfurt am Main, Germany). The enzymes were produced in E. coli BL21-Gold(DE3) competent cells (Agilent, Santa Clara, CA, USA). The expressions of SaSAHH, SfSAHH and TkSAHH were performed in E. coli BL21-CodonPlus (DE3)-RIPL competent cells (Agilent, Santa Clara, CA, USA). LB medium was used for most seed cultures and main cultures, SaSAHH, SfSAHH and TkSAHH were produced in 2xYT medium. Seed cultures (5 mL) were grown in LB medium with the corresponding antibiotics at 37 °C overnight. The main culture (400 mL plus added seed culture) was grown in medium supplemented with the needed antibiotics at 37 °C. When the OD600 reached 0.5, expression was induced by the addition of isopropyl-β-d-thiogalactopyranoside (IPTG; final concentration 0.25 mm, 1 mm for PfuSAHH) and the cultures were shaken at 160 rpm for 18 h at 20 °C. The cells were harvested by centrifugation and lysed by sonication [Branson Sonifier 250, Emerson, St. Louis, MO, USA (duty cycle 50%, intensity 50%, 5 × 30 s with 30 s breaks)] in lysis buffer. The lysis buffer was either 50 mm Tris-HCl, pH 7.4, 500 mm NaCl, 10% (w/v) glycerol for McSAHH, MeSAHH, MhSAHH, MiSAHH, MjSIHH, MmaSAHH, MtSAHH, PfuSAHH, SacSAHH, SsoSAHH and TkSAHH; or 40 mm Tris-HCl, pH 8.0, 100 mm NaCl, 10% (w/v) glycerol for CgSAHH, LlSAHH, MjDadD, MmSAHH, PaSAHH, SaSAHH, ScHSMT, SfSAHH, and TmSAHH. After centrifugation, the proteins were purified by nickel-NTA affinity chromatography [lysis buffer including low concentrations (10 or 10–50 mm) imidazole for washing or high concentrations (200 or 100–300 mm) for eluting the protein], and desalted using a PD-10 column (Cytiva Europe GmbH, Freiburg im Breisgau, Germany). The storage buffer for the enzymes was the same as the lysis buffer. Protein concentration was determined using a NanoDrop 2000, at 280 nm with the molecular weight (including the His6-tag, Supplementary Table S1 online), and the protein extinction coefficient (calculated with the ExPASy ProtParam tool60).

Crystallisation and data collection

PfuSAHH with inosine (2 mm) co-crystals appeared after 2–4 days by using the sitting drop vapor diffusion methods at room temperature by combining 0.5 μL of protein at 10 mg/mL with 0.5 μL of a precipitant solution comprising 26% (w/v) PEG 1500 with 100 mm malic acid/MES/Tris-HCl buffer (MMT), pH 8.0. PfuSAHH treated at 95 °C (368 K) for 15 min was also co-crystallized with inosine and the crystals appeared after 2–4 days. PfuSAHH with SIH co-crystals were obtained with slightly modified crystallisation conditions comprising 28% (w/v) PEG 2000 with 100 mm MMT, pH 8.0. MmaSAHH (10 mg/mL) with inosine (2 mm) co-crystals were obtained within a week at 22 °C in sitting drops by mixing 0.5 µL of the protein solution with an equal volume of reservoir solution containing 28% (w/v) PEG 3350, 100 mm MMT, pH 8.0. SacSAHH (10 mg/mL) with adenosine (2 mm) co-crystals were obtained within a week at 22 °C in sitting drops by mixing 0.5 µL of the protein solution with an equal volume of reservoir solution containing 20% (w/v) PEG 3350 with 200 mm ammonium iodide. MmSAHH with inosine (4 mm) co-crystals appeared after 4 days by using the sitting drop vapor diffusion methods at room temperature by combining 2 μL of protein at 4 mg/mL with 1 μL of a precipitant solution comprising 22% (w/v) PEG 3350 with 180 mm sodium formate, pH 6.9. Prior to data collection, the crystals were transferred to a cryosolution containing the respective mother liquor reservoir solutions and flash frozen in liquid nitrogen. Datasets were collected at 100 K at the Swiss Light Source (SLS) on macromolecular crystallography beamline PXI-X06SA. All PfuSAHH crystals were maintained at a constant temperature (100 K) and a total of 900 images (Δφ = 0.2°/image) for inosine complex, and 1800 images (Δφ = 0.2°/image) for the SIH complex were recorded separately for each on an EIGER 16 M (Dectris) detector. The datasets were extending up to 2.3 Å resolution for inosine complex, and up to 2.0 Å for the SIH complex. All datasets were processed by XDS59 in P42212 space group (a = b = 111.68, c = 121.59; α = β = γ = 90°). MmaSAHH crystals were flash-cooled and maintained at a constant temperature at 100 K in a cold nitrogen-gas stream. A dataset with a total of 900 images (Δφ = 0.2°/image) were recorded on an EIGER 16 M (Dectris) detector. The datasets were extending up to 2.5 Å resolution in P21 space group (a = 65.76, b = 328.9, c = 82.05; α = γ = 90°, β = 107.2°). SacSAHH crystals were maintained at a constant temperature (100 K) and a total of 3600 images (Δφ = 0.1°/image) were recorded on a EIGER 16 M (Dectris) detector with data extending up to 2.6 Å resolution. The datasets were processed in P1 space group (a = 84.36, b = 88.36, c = 138.54; α = 78.86°, β = 74.85°, γ = 64.85°). MmSAHH crystals were maintained at a constant temperature (100 K) and a total of 900 images (Δφ = 0.1°∙image−1) were recorded on an EIGER 16 M (Dectris) detector with data extending up to 2.48 Å resolution. The datasets were processed by XDS59 in I222 space group (a = 97.78, b = 101.96, c = 172.58; α = β = γ = 90°). All the data were integrated by using XDS61 then merged and scaled using SCALA from the CCP4 suite of programs62,63. The data collection statistics are summarised in Table 3.

Table 3.

Data collection and refinement statistics (Molecular Replacement)

MmaSAHH•NAD•inosine PfuSAHH•NAD•inosine PfuSAHH•NAD•inosine (95 °C) PfuSAHH•NAD•SIH SacSAHH•NAD•adenosine MmSAHH•NAD•inosine
Data collection
Space group P21 P42212 P42212 P42212 P1 I222
Cell dimensions
   a, b, c (Å) 65.8, 328.9, 85.1 112.5, 112.5, 122.8 111.7, 111.7, 122.1 111.7, 111.7, 121.6 84.4, 88.4, 138.6 98.2, 102.5, 173.4
   α, β, γ (°) 90, 107.2, 90 90, 90, 90 90, 90, 90 90, 90, 90 78.9, 74.9, 64.9 90, 90, 90
Resolution [Å]

45.44–2.65

(2.74–2.65)

48.62–2.28

(2.37–2.28)

48.31–2.03

(2.11–2.03)

53.4–2.05

(2.12–2.05)

46.16–2.50

(2.59–2.50)

54.9–2.48

(2.56–2.48)

Rmerge

0.1748

(1.075)

0.1495

(1.191)

0.2373

(2.425)

0.1048

(0.9204)

0.1348

(0.582)

0.177

(0.97)

II

6.73

(2.13)

13.51

(1.66)

15.36

(1.54)

16.82 (2.70)

6.67

(2.35)

7.8

(2.1)

Completeness [%]

97.3

(98.2)

99.8

(98.8)

99.7

(97.6)

99.7

(99.9)

87.5

(85.9)

98.8

(99)

Redundancy

3.6

(3.5)

12.7

(8.3)

26.8

(26.6)

12.8

(13.4)

3.6

(3.6)

5.7

(5.9)

Refinement
Resolution [Å]

45.44–2.65

(2.74–2.65)

48.62–2.28

(2.37–2.28)

48.31–2.03

(2.11–2.03)

53.4–2.05

(2.12–2.05)

46.16–2.50

(2.59–2.50)

54.9–2.48

(2.56–2.48)

No. reflections

141280

(13525)

36333

(3519)

50113

(4818)

48676

(4780)

105739

(10341)

31048

(3056)

Rwork /Rfree [%] 18.8/24.3 16.1/21.6 15.5/20.3 17.6/21.9 22.9/28.2 17.0/21.8
No. atoms 26322 6891 7086 7147 27556 7067
   Protein 25440 6604 6660 6706 25760 6650
   Ligand/ion 608 126 126 88 504 128
   Water 274 161 300 353 1292 289
B-factors 67.14 46.77 35.81 38.41 40.96 40.98
   Protein 67.59 46.98 35.67 38.16 40.23 41.16
   Ligand/ion 55.84 38.49 28.84 34.81 31.83 35.81
   Water 50.24 44.84 41.95 44.11 59.02 39.23
R.m.s. deviations
   Bond lengths (Å) 0.030 0.014 0.009 0.014 0.008 0.014
   Bond angles (°) 2.33 1.81 1.48 1.84 1.69 1.86

Each structure was solved from a single crystal. Values in parentheses are for highest-resolution shell.

Structure determination and refinement

Initial phases were determined by molecular replacement using PHASER. Best solutions were obtained using 5AXA based homology model as the starting model for PfuSAHH, 1V8B for MmaSAHH and 3H9U for SacSAHH. The asymmetric unit (ASU) of PfuSAHH crystals contained a dimer, whereas MmaSAHH comprised four dimers and SacSAHH comprised two dimers. The models were built with COOT63, and refinements were carried out with REFMAC using NCS constraints with or without TLS parameters64. The NAD+ ligands in all the complex crystals were clearly observed in the initial 2Fo-Fc and Fo-Fc maps. To improve the model of the bound substrate and product, we calculated both 2Fo-Fc maps and POLDER omit maps65 and fitted the ligands into the respective electron densities, which allowed unambiguous identification of the ligand positioning (Supplementary Fig. S31 online). Incorporation of non-crystallographic symmetry (NCS) restraints greatly expedited model improvement. For PfuSAHH•NAD•inosine complex, a Ramachandran plot calculation indicated that 97% and 3% of the residues occupy the most favored and additionally allowed regions, respectively. For PfuSAHH•NAD•SIH complex, a Ramachandran plot calculation indicated that 96% and 4% of the residues occupy the most favored and additionally allowed regions, respectively. For MmaSAHH•NAD•inosine complex, a Ramachandran plot calculation indicated that 96% and 3% of the residues occupy the most favored and additionally allowed regions, respectively. For SacSAHH•NAD•adenosine complex, a Ramachandran plot calculation indicated that 94% and 5% of the residues occupy the most favored and additionally allowed regions, respectively. For MmSAHH•NAD•inosine complex, a Ramachandran plot calculation indicated that 97% and 3% of the residues occupy the most favored and additionally allowed regions, respectively. Analysis of the SAHH structures and comparison with other SAHH structures were carried out using PyMOL66.

NMR spectroscopy

Nuclear magnetic resonance (NMR) spectra were recorded on an Avance DRX 400 spectrometer (Bruker, Billerica, MA, USA), operating at 400.1 MHz (for 1H NMR) and 100.6 MHz (for 13C NMR). All measurements were performed at 25 °C. Spectra were analysed with TopSpin 3.6.2.

HPLC analysis

All available substrates and products of the enzymatic reactions are used as authentic reference standards and the retention times are listed in Supplementary Table S3 online. All assays were analysed with an Agilent 1100 Series HPLC using an ISAspher SCX 100-5 column (250 mm × 4.6 mm, 5 µm; ISERA GmbH, Düren, Germany). For the HPLC method67, 40 mm sodium acetate, pH 4.2, (buffer A), and acetonitrile (buffer B) were used as mobile phase. A stepwise gradient [0–4 min: 100% A (1.3 mL/min); 4–10 min:70% A, 30% B, (1.1 mL/min); 10–20 min: 100% A (1.3 mL/min, re-equilibration)] was used for the elution. The injection volume was set to 10 µL.

SIH enzymatic synthesis and structure verification

SIH was enzymatically synthesised with a 5´-deoxyadenosine deaminase (MjDadD) starting from SAH following a published protocol with modifications13,14. 1 mm SAH was incubated with 1 µm MjDadD in 50 mm Tris-HCl buffer, pH 8.0, for 20 h at 37 °C. The enzyme was removed with a spin filter and full conversion checked with HPLC-DAD. The stock solution of SIH (1 mm) was stored at −20 °C. The structure was verified by NMR analysis by running six parallel assays with 4 mL reaction tube and combining them in one 100 mL flask. The solution was freeze-dried, and the powder was resuspended in 700 µL D2O and measured with NMR spectroscopy. SIH has been isolated from Streptomyces flocculus (Streptomyces albus ATCC 13257) previously and the structure was confirmed by UV spectrum and 1H- NMR analysis16. An HPLC method was used to track the conversion from SAH to SIH catalysed by MjDadD (Supplementary Fig. S1 online), here the UV spectra matched the described absorbance maximum shift from 260 nm (SAH) to 248 nm (SIH; Supplementary Fig. S1 online). 1H NMR data (Supplementary Fig. S2B online) obtained matched the published data and was extended by measuring the 13C-NMR spectrum (Supplementary Fig. S2C online), as well as 2D spectra (Supplementary Figs. S2D–F online) to further confirm the SIH structure.

Enzyme activity assays

In general, all assays were performed at least in triplicates. Assays concerning SAHHs/SIHHs were performed in 50 mm Tris-HCl, pH 7.5, for 20 h at 37 °C in 200 µL reaction volume, if not otherwise stated. For the synthesis reaction, 0.5 mm Hcy and 0.5 mm nucleoside were added, while the cleavage reaction was started with 0.2 mm of either SAH or SIH. The SAHH/SIHH was added at 5 µM. A second enzyme, ScHSMT (10 µM), and its methyl donor S-Methyl-l-methionine (1 mm) were added to the SAH or SIH cleavage to drive the reaction forward. For assays performed at 70 °C, ScHSMT was replaced by DTNB (300 µM). After incubation, 150 µL of the assay sample was added to 50 µL of perchloric acid [final concentration 2.5% (w/v)] to stop the reaction and spun down for 30 min prior transferring 80 µL to an HPLC vial. All investigated SAHHs and SIHHs were tested in the SAH and SIH cleavage, as well as synthesis direction. An overview can be found in Table 1, while the HPLC chromatograms are given in Supplementary Figs. S4S21 and the SDS gels in Supplementary Fig. S3 online.

Bioinformatical analysis of amino acid sequences

Alignments of amino acid sequences were performed either with Clustal Omega or T-Coffee online services68,69. To visualise and annotate the sequence alignment, Jalview Version2 was used70. For the visualisation of the phylogenetic tree, the MEGA11 software was used71.

Statistics and reproducibility

All the experiments were performed at least in triplicates. Substrate conversions were analysed semi-quantitative by using peak areas. All data presented here were reliably reproducible.

Reporting summary

Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.

Supplementary information

Peer review file (4.7MB, pdf)
42003_2024_6078_MOESM3_ESM.docx (12.6KB, docx)

Description of additional supplementary files

Supplementary Data 1 (13.1MB, xlsx)
Reporting Summary (832.9KB, pdf)

Acknowledgements

This work was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – 235777276/RTG1976 and 527572100. This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (Grant agreement No. 716966). We thank Jun.-Prof. Dr Silja Mordhorst (now University of Tübingen) for construction of some plasmids used in this work, and Prof. Dr Andreas Bechthold for the donation of gDNA from S. albus J1074. We thank Emina Čokljat and Katharina Strack for assistance with protein production and purification. We thank Dr. Tomizaki Takashi and the PXI (X06SA) beamline staff of the Swiss Light Source, Paul Scherrer Institute (Villigen, Switzerland) for support in crystallographic data collection. We thank Sascha Ferlaino and Dr Philippe Bisel (both University of Freiburg) for NMR measurements and interpretation of the results, respectively. Prof. Dr Sonja-Verena Albers (University of Freiburg) is acknowledged for sharing her expertise regarding archaea and for critically reading the manuscript; as well as Prof. Dr Michael Müller (University of Freiburg) for helpful discussions on the binding modes and mechanisms.

Author contributions

L.-H.K.: conceptualisation, methodology, investigation; writing - review and editing, and visualisation; D.P.: conceptualisation, methodology, investigation, writing - original draft preparation, writing - review and editing, and visualisation; R.S.-B.: conceptualisation, methodology, investigation, writing - original draft preparation, writing - review and editing, and visualisation; P.G.: data interpretation, and writing - review and editing; J.N.A.: conceptualisation, writing - review and editing, supervision, project administration, resources, and funding acquisition.

Peer review

Peer review information

Communications Biology thanks Jeremy Lott, Krzysztof Brzeziński, and Kozo Tomita for their contribution to the peer review of this work. Primary Handling Editors: Isabelle Lucet and Tobias Goris. A peer review file is available.

Funding

Open Access funding enabled and organized by Projekt DEAL.

Data availability

The single chromatograms used to determine the substrate preferences can be found in the Supplementary information online (Fig. S4: SacSAHH, Fig. S5: SsoSAHH, Fig. S6: McSAHH, Fig. S7: MeSAHH, Fig. S8: MhSAHH, Fig. S9: MiSAHH, Fig. S10: MjSIHH, Fig. S11: MmaSAHH, Fig. S12: MtSAHH, Fig. S13: PfuSAHH, Fig. S14: TkSAHH, Fig. S15: CgSAHH, Fig. S16: PaSAHH, Fig. S17: SaSAHH, Fig. S18: SfSAHH, Fig. S19: TmSAHH, Fig. S20: LlSAHH, Fig. S21: MmSAHH). Source data underlying the chromatograms presented in Fig. 3b and c as well as the Supplementary Figs. S4S24 can be found in Supplementary Data 1 or online in the data Repository of the University of Stuttgart72. Supplementary Figs. S33 and S34 contain the original uncropped and unedited gel images of Supplementary Fig. S3. Maps and models have been deposited in the PDB with the accession codes: 7R37, 7R38, 7R39,7R3A, 8COD and 8QNO. All other data supporting the findings of this study are available from the corresponding author upon reasonable request.

Code availability

Protein homologues were searched using NCBI BLASTP47 with the standard algorithm parameters. To obtain more relevant results, the number of ‘Max target sequences’ and the ‘Expect threshold’ were set to 1,000 and 0.01, respectively. Alignments of amino acid sequences were performed either with Clustal Omega or T-Coffee online services68,69 using the standard parameters. To visualise and annotate the sequence alignment, Jalview Version2 was used70. For the visualisation of the phylogenetic tree, the MEGA11 software was used71. Analysis of the SAHH structures and comparison with other SAHH structures were carried out using PyMOL66.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

These authors contributed equally: Lars-Hendrik Koeppl, Désirée Popadić, Raspudin Saleem-Batcha.

Supplementary information

The online version contains supplementary material available at 10.1038/s42003-024-06078-9.

References

  • 1.Asai A, et al. One-carbon metabolism for cancer diagnostic and therapeutic approaches. Cancer Lett. 2020;470:141–148. doi: 10.1016/j.canlet.2019.11.023. [DOI] [PubMed] [Google Scholar]
  • 2.Cavalli G, Heard E. Advances in epigenetics link genetics to the environment and disease. Nature. 2019;571:489–499. doi: 10.1038/s41586-019-1411-0. [DOI] [PubMed] [Google Scholar]
  • 3.Greenberg MVC, Bourc’his D. The diverse roles of DNA methylation in mammalian development and disease. Nat. Rev. Mol. Cell Biol. 2019;20:590–607. doi: 10.1038/s41580-019-0159-6. [DOI] [PubMed] [Google Scholar]
  • 4.Cantoni GL, Scarano E. The formation of S-adenosylhomocysteine in enzymatic transmethylation reactions. J. Am. Chem. Soc. 1954;76:4744–4744. [Google Scholar]
  • 5.Struck A-W, Thompson ML, Wong LS, Micklefield J. S-Adenosyl-methionine-dependent methyltransferases: highly versatile enzymes in biocatalysis, biosynthesis and other biotechnological applications. Chem. Bio. Chem. 2012;13:2642–2655. doi: 10.1002/cbic.201200556. [DOI] [PubMed] [Google Scholar]
  • 6.Deguchi T, Barchas J. Inhibition of transmethylations of biogenic amines by S-adenosylhomocysteine: enhancement of transmethylation by adenosylhomocysteinase. J. Biol. Chem. 1971;246:3175–3181. [PubMed] [Google Scholar]
  • 7.Walker RD, Duerre JA. S-adenosylhomocysteine metabolism in various species. Can. J. Biochem. 1975;53:312–319. doi: 10.1139/o75-044. [DOI] [PubMed] [Google Scholar]
  • 8.Cantoni, G. L. & Chiang, P. K. The Role of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase in the control of biological methylations. in Natural Sulfur Compounds (eds. Cavallini, D., Gaull, G. E. & Zappia, V.) 67–80 (Springer, Boston, MA, 1980). 10.1007/978-1-4613-3045-5_6.
  • 9.Shapiro SK. Adenosylmethionine-homocysteine transmethylase. Biochim. Biophys. Acta. 1958;29:405–409. doi: 10.1016/0006-3002(58)90199-9. [DOI] [PubMed] [Google Scholar]
  • 10.Finkelstein JD, Harris BJ, Kyle WE. Methionine metabolism in mammals: kinetic study of betaine-homocysteine methyltransferase. Arch. Biochem. Biophys. 1972;153:320–324. doi: 10.1016/0003-9861(72)90451-1. [DOI] [PubMed] [Google Scholar]
  • 11.Banerjee RV, Matthews RG. Cobalamin-dependent methionine synthase. FASEB J. 1990;4:1450–1459. doi: 10.1096/fasebj.4.5.2407589. [DOI] [PubMed] [Google Scholar]
  • 12.Stępkowski T, Brzeziński K, Legocki AB, Jaskólski M, Béna G. Bayesian phylogenetic analysis reveals two-domain topology of S-adenosylhomocysteine hydrolase protein sequences. Mol. Phylogenetics Evol. 2005;34:15–28. doi: 10.1016/j.ympev.2004.09.008. [DOI] [PubMed] [Google Scholar]
  • 13.Miller D, O’Brien K, Xu H, White RH. Identification of a 5′-deoxyadenosine deaminase in Methanocaldococcus jannaschii and its possible role in recycling the radical S-adenosylmethionine enzyme reaction product 5′-deoxyadenosine. J. Bacteriol. 2014;196:1064–1072. doi: 10.1128/JB.01308-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Miller D, Xu H, White RH. S-inosyl-L-homocysteine hydrolase, a novel enzyme involved in S-adenosyl-L-methionine recycling. J. Bacteriol. 2015;197:2284–2291. doi: 10.1128/JB.00080-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Hermann JC, et al. Structure-based activity prediction for an enzyme of unknown function. Nature. 2007;448:775–779. doi: 10.1038/nature05981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Speedie MK, Zulty JJ, Brothers P. S-adenosylhomocysteine metabolism in Streptomyces flocculus. J. Bacteriol. 1988;170:4376–4378. doi: 10.1128/jb.170.9.4376-4378.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Zulty JJ, Speedie MK. Purification and characterization of S-adenosylhomocysteine deaminase from streptonigrin-producing Streptomyces flocculus. J. Bacteriol. 1989;171:6840–6844. doi: 10.1128/jb.171.12.6840-6844.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Shimizu S, Shiozaki S, Ohshiro T, Yamada H. Occurrence of S-adenosylhomocysteine hydrolase in prokaryote cells. Eur. J. Biochem. 1984;141:385–392. doi: 10.1111/j.1432-1033.1984.tb08203.x. [DOI] [PubMed] [Google Scholar]
  • 19.Brzezinski K. S-adenosyl-L-homocysteine hydrolase: a structural perspective on the enzyme with two Rossmann-fold domains. Biomolecules. 2020;10:1682. doi: 10.3390/biom10121682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Ueland PM. Pharmacological and biochemical aspects of S-adenosylhomocysteine and S-adenosylhomocysteine hydrolase. Pharmacol. Rev. 1982;34:223–253. [PubMed] [Google Scholar]
  • 21.De la Haba G, Cantoni GL. The enzymatic synthesis of S-adenosyl-L-homocysteine from adenosine and homocysteine. J. Biol. Chem. 1959;234:603–608. [PubMed] [Google Scholar]
  • 22.Richards HH, Chiang PK, Cantoni GL. Adenosylhomocysteine hydrolase. Crystallization of the purified enzyme and its properties. J. Biol. Chem. 1978;253:4476–4480. [PubMed] [Google Scholar]
  • 23.Palmer JL, Abeles RH. The mechanism of action of S-adenosylhomocysteinase. J. Biol. Chem. 1979;254:1217–1226. [PubMed] [Google Scholar]
  • 24.Takata Y, et al. Catalytic mechanism of S-adenosylhomocysteine hydrolase site-directed mutagenesis of Asp-130, Lys-185, Asp-189, and Asn-190. J. Biol. Chem. 2002;277:22670–22676. doi: 10.1074/jbc.M201116200. [DOI] [PubMed] [Google Scholar]
  • 25.Yamada T, et al. Catalytic mechanism of S-adenosylhomocysteine hydrolase: Roles of His 54, Asp130, Glu155, Lys185, and Aspl89. Int. J. Biochem. Cell Biol. 2005;37:2417–2435. doi: 10.1016/j.biocel.2005.06.009. [DOI] [PubMed] [Google Scholar]
  • 26.Kusakabe Y, et al. Structural insights into the reaction mechanism of S-adenosyl-L-homocysteine hydrolase. Sci. Rep. 2015;5:16641. doi: 10.1038/srep16641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Zheng Y, et al. Crystal structures of S-adenosylhomocysteine hydrolase from the thermophilic bacterium Thermotoga maritima. J. Struct. Biol. 2015;190:135–142. doi: 10.1016/j.jsb.2015.03.002. [DOI] [PubMed] [Google Scholar]
  • 28.Manszewski T, Singh K, Imiolczyk B, Jaskolski M. An enzyme captured in two conformational states: crystal structure of S-adenosyl-L-homocysteine hydrolase from Bradyrhizobium elkanii. Acta. Cryst. 2015;D71:2422–2432. doi: 10.1107/S1399004715018659. [DOI] [PubMed] [Google Scholar]
  • 29.Hu Y, et al. Crystal Structure of S-Adenosylhomocysteine Hydrolase from Rat Liver. Biochemistry. 1999;38:8323–8333. doi: 10.1021/bi990332k. [DOI] [PubMed] [Google Scholar]
  • 30.Belužić R, et al. A single mutation at Tyr143 of human S-adenosylhomocysteine hydrolase renders the enzyme thermosensitive and affects the oxidation state of bound cofactor nicotinamide–adenine dinucleotide. Biochem. J. 2006;400:245–253. doi: 10.1042/BJ20060749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Reddy MCM, et al. Crystal structures of Mycobacterium tuberculosis S-adenosyl-L-homocysteine hydrolase in ternary complex with substrate and inhibitors. Protein Sci. 2008;17:2134–2144. doi: 10.1110/ps.038125.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Brzezinski K, Dauter Z, Jaskolski M. High-resolution structures of complexes of plant S-adenosyl-L-homocysteine hydrolase (Lupinus luteus) Acta. Cryst. 2012;D68:218–231. doi: 10.1107/S0907444911055090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Bujnicki JM, Prigge ST, Caridha D, Chiang PK. Structure, evolution, and inhibitor interaction of S-adenosyl-L-homocysteine hydrolase from Plasmodium falciparum. Proteins. 2003;52:624–632. doi: 10.1002/prot.10446. [DOI] [PubMed] [Google Scholar]
  • 34.Czyrko J, et al. Metal-cation regulation of enzyme dynamics is a key factor influencing the activity of S-adenosyl-L-homocysteine hydrolase from Pseudomonas aeruginosa. Sci. Rep. 2018;8:11334. doi: 10.1038/s41598-018-29535-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Lozada-Ramírez JD, Sánchez-Ferrer A, García-Carmona F. Recombinant S-adenosylhomocysteine hydrolase from Thermotoga maritima: Cloning, overexpression, characterization, and thermal purification studies. Appl. Biochem. Biotechnol. 2013;170:639–653. doi: 10.1007/s12010-013-0218-y. [DOI] [PubMed] [Google Scholar]
  • 36.Porcelli M, et al. S‐adenosylhomocysteine hydrolase from the archaeon Pyrococcus furiosus: Biochemical characterization and analysis of protein structure by comparative molecular modeling. Proteins. 2005;58:815–825. doi: 10.1002/prot.20381. [DOI] [PubMed] [Google Scholar]
  • 37.Lozada-Ramírez JD, Martínez-Martínez I, Sánchez-Ferrer A, García-Carmona F. A colorimetric assay for S-adenosylhomocysteine hydrolase. J. Biochem. Biophys. Meth. 2006;67:131–140. doi: 10.1016/j.jbbm.2006.01.008. [DOI] [PubMed] [Google Scholar]
  • 38.Kailing LL, Bertinetti D, Herberg FW, Pavlidis IV. A coupled photometric assay for characterization of S-adenosyl-L-homocysteine hydrolases in the physiological hydrolytic direction. N. Biotechnol. 2017;39:11–17. doi: 10.1016/j.nbt.2017.04.005. [DOI] [PubMed] [Google Scholar]
  • 39.Ueland PM, Saebø J. Cyclic AMP-adenosine binding protein/S-adenosylhomocysteinase from mouse liver: A fraction of adenosine bound is converted to adenine. Biochim. Biophys. Acta. 1979;585:512–526. doi: 10.1016/0304-4165(79)90184-3. [DOI] [PubMed] [Google Scholar]
  • 40.Singhal A, et al. Regulation of homocysteine metabolism by Mycobacterium tuberculosis S-adenosylhomocysteine hydrolase. Sci. Rep. 2013;3:2264. doi: 10.1038/srep02264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Matuszewska B, Borchardt RT. The role of nicotinamide adenine dinucleotide in the inhibition of bovine liver S-adenosylhomocysteine hydrolase by neplanocin A. J. Biol. Chem. 1987;262:265–268. [PubMed] [Google Scholar]
  • 42.Brzezinski K, et al. S-adenosyl-L-homocysteine hydrolase from a hyperthermophile (Thermotoga maritima) is expressed in Escherichia coli in inactive form – Biochemical and structural studies. Int. J. Biol. Macromol. 2017;104:584–596. doi: 10.1016/j.ijbiomac.2017.06.065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Porcelli M, Fusco S, Inizio T, Zappia V, Cacciapuoti G. Expression, purification, and characterization of recombinant S-adenosylhomocysteine hydrolase from the thermophilic archaeon Sulfolobus solfataricus. Protein Expr. Purif. 2000;18:27–35. doi: 10.1006/prep.1999.1161. [DOI] [PubMed] [Google Scholar]
  • 44.Popadić D, et al. A bicyclic S-adenosylmethionine regeneration system applicable with different nucleosides or nucleotides as cofactor building blocks. RSC Chem. Biol. 2021;2:883–891. doi: 10.1039/d1cb00033k. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Ellman GL. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959;82:70–77. doi: 10.1016/0003-9861(59)90090-6. [DOI] [PubMed] [Google Scholar]
  • 46.Leibniz Institute, DSMZ-German Collection of Microorganisms and Cell Cultures GmbH. (https://www.dsmz.de) DSM 24694, DSM 3721, DMS 3094, DSM 11812, DSM 4774. (2023).
  • 47.Altschul SF, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997;25:3389–3402. doi: 10.1093/nar/25.17.3389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.The UniProt Consortium. et al. UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2023;51:D523–D531. doi: 10.1093/nar/gkac1052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Koonin EV, Makarova KS, Aravind L. Horizontal gene transfer in prokaryotes: Quantification and classification. Annu. Rev. Microbiol. 2001;55:709–742. doi: 10.1146/annurev.micro.55.1.709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Yamada T, et al. Structure and function of eritadenine and its 3-deaza analogues: Potent inhibitors of S-adenosylhomocysteine hydrolase and hypocholesterolemic agents. Biochem. Pharmacol. 2007;73:981–989. doi: 10.1016/j.bcp.2006.12.014. [DOI] [PubMed] [Google Scholar]
  • 51.Tanaka N, et al. Crystal Structure of S-Adenosyl-L-Homocysteine Hydrolase from the Human Malaria Parasite Plasmodium falciparum. J. Mol. Biol. 2004;343:1007–1017. doi: 10.1016/j.jmb.2004.08.104. [DOI] [PubMed] [Google Scholar]
  • 52.Malecki PH, et al. Biochemical and structural insights into an unusual, alkali-metal-independent S-adenosyl-L-homocysteine hydrolase from Synechocystis sp. PCC 6803. Acta Crystallogr. D. 2022;78:865–882. doi: 10.1107/S2059798322005605. [DOI] [PubMed] [Google Scholar]
  • 53.Markova N, Enchev V. Tautomerism of inosine in water: Is it possible? J. Phys. Chem. B. 2019;123:622–630. doi: 10.1021/acs.jpcb.8b11316. [DOI] [PubMed] [Google Scholar]
  • 54.Kusakabe, Y., Ishihara, M. & Tanaka, N. Crystal structure of mouse SAHH complexed with adenosine. 10.2210/pdb5AXA/pdb (2016).
  • 55.Kailing LL, et al. S-Adenosyl-L-Homocysteine Hydrolase Inhibition by a Synthetic Nicotinamide Cofactor Biomimetic. Front. Microbiol. 2018;9:505. doi: 10.3389/fmicb.2018.00505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Manszewski T, Szpotkowski K, Jaskolski M. Crystallographic and SAXS studies of S-adenosyl-L-homocysteine hydrolase from Bradyrhizobium elkanii. IUCrJ. 2017;4:271–282. doi: 10.1107/S2052252517002433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Yang X, et al. Catalytic Strategy of S -Adenosyl- l -homocysteine Hydrolase: Transition-State Stabilization and the Avoidance of Abortive Reactions. Biochemistry. 2003;42:1900–1909. doi: 10.1021/bi0262350. [DOI] [PubMed] [Google Scholar]
  • 58.Krissinel E, Henrick K. Inference of Macromolecular Assemblies from Crystalline State. J. Mol. Biol. 2007;372:774–797. doi: 10.1016/j.jmb.2007.05.022. [DOI] [PubMed] [Google Scholar]
  • 59.Hachisuka S-I, Sato T, Atomi H. Hyperthermophilic Archaeon Thermococcus kodakarensis Utilizes a Four-Step Pathway for NAD+ Salvage through Nicotinamide Deamination. J. Bacteriol. 2018;200:e00785–17. doi: 10.1128/JB.00785-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Gasteiger, E. et al. Protein identification and analysis tools on the ExPASy server. in The Proteomics Protocols Handbook (ed. Walker, J. M.) 571–607 (Humana Press, 2005). 10.1385/1-59259-890-0:571.
  • 61.Kabsch W. XDS. Acta. Cryst. 2010;D66:125–132. doi: 10.1107/S0907444909047337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Evans P. Scaling and assessment of data quality. Acta Cryst. 2006;D62:72–82. doi: 10.1107/S0907444905036693. [DOI] [PubMed] [Google Scholar]
  • 63.Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Cryst. 2004;D60:2126–2132. doi: 10.1107/S0907444904019158. [DOI] [PubMed] [Google Scholar]
  • 64.Murshudov GN, et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Cryst. 2011;D67:355–367. doi: 10.1107/S0907444911001314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Liebschner D, et al. Polder maps: improving OMIT maps by excluding bulk solvent. Acta Cryst. 2017;D73:148–157. doi: 10.1107/S2059798316018210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.The PyMOL Molecular Graphics System, Version 2.5.0 Schrödinger, LLC.
  • 67.Siegrist J, et al. Regiocomplementary O-methylation of catechols by using three-enzyme cascades. Chem. Bio. Chem. 2015;16:2576–2579. doi: 10.1002/cbic.201500410. [DOI] [PubMed] [Google Scholar]
  • 68.Madeira F, et al. Search and sequence analysis tools services from EMBL-EBI in 2022. Nucleic Acids Res. 2022;50:W276–W279. doi: 10.1093/nar/gkac240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Notredame C, Higgins DG, Heringa J. T-coffee: a novel method for fast and accurate multiple sequence alignment 1 1Edited by J. Thornton. J. Mol. Biol. 2000;302:205–217. doi: 10.1006/jmbi.2000.4042. [DOI] [PubMed] [Google Scholar]
  • 70.Waterhouse AM, Procter JB, Martin DMA, Clamp M, Barton GJ. Jalview Version 2–a multiple sequence alignment editor and analysis workbench. Bioinformatics. 2009;25:1189–1191. doi: 10.1093/bioinformatics/btp033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Tamura K, Stecher G, Kumar S. MEGA11: Molecular Evolutionary Genetics Analysis Version 11. Mol. Biol. Evol. 2021;38:3022–3027. doi: 10.1093/molbev/msab120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Koeppl, L. -H. HPLC raw data related to Koeppl et al.: Structure, function and substrate preferences of archaeal S-adenosyl-L-homocysteine hydrolases. DaRUS10.18419/darus-4052 (2024). [DOI] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Peer review file (4.7MB, pdf)
42003_2024_6078_MOESM3_ESM.docx (12.6KB, docx)

Description of additional supplementary files

Supplementary Data 1 (13.1MB, xlsx)
Reporting Summary (832.9KB, pdf)

Data Availability Statement

The single chromatograms used to determine the substrate preferences can be found in the Supplementary information online (Fig. S4: SacSAHH, Fig. S5: SsoSAHH, Fig. S6: McSAHH, Fig. S7: MeSAHH, Fig. S8: MhSAHH, Fig. S9: MiSAHH, Fig. S10: MjSIHH, Fig. S11: MmaSAHH, Fig. S12: MtSAHH, Fig. S13: PfuSAHH, Fig. S14: TkSAHH, Fig. S15: CgSAHH, Fig. S16: PaSAHH, Fig. S17: SaSAHH, Fig. S18: SfSAHH, Fig. S19: TmSAHH, Fig. S20: LlSAHH, Fig. S21: MmSAHH). Source data underlying the chromatograms presented in Fig. 3b and c as well as the Supplementary Figs. S4S24 can be found in Supplementary Data 1 or online in the data Repository of the University of Stuttgart72. Supplementary Figs. S33 and S34 contain the original uncropped and unedited gel images of Supplementary Fig. S3. Maps and models have been deposited in the PDB with the accession codes: 7R37, 7R38, 7R39,7R3A, 8COD and 8QNO. All other data supporting the findings of this study are available from the corresponding author upon reasonable request.

Protein homologues were searched using NCBI BLASTP47 with the standard algorithm parameters. To obtain more relevant results, the number of ‘Max target sequences’ and the ‘Expect threshold’ were set to 1,000 and 0.01, respectively. Alignments of amino acid sequences were performed either with Clustal Omega or T-Coffee online services68,69 using the standard parameters. To visualise and annotate the sequence alignment, Jalview Version2 was used70. For the visualisation of the phylogenetic tree, the MEGA11 software was used71. Analysis of the SAHH structures and comparison with other SAHH structures were carried out using PyMOL66.


Articles from Communications Biology are provided here courtesy of Nature Publishing Group

RESOURCES